[1]
R. Castelli, “BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.”, Mediterr J Hematol Infect Dis, vol. 8, p. e2016030, Jul. 2016.